France Intravenous Infusion Pumps Market

France Intravenous Infusion Pumps Market Insights Forecasts to 2035

• The France Intravenous Infusion Pumps Market Size Was Estimated at USD 219.5 Million in 2024.
• The France Intravenous Infusion Pumps Market Size is Expected to Grow at a CAGR of Around 8.5% from 2025 to 2035.
• The France Intravenous Infusion Pumps Market Size is Expected to Reach USD 538.2 Million by 2035.

According to a research report published by Decision Advisors & Consulting, the France Intravenous Infusion Pumps Market Size is projected to reach 538.2 million by 2035, growing at a CAGR of 8.5% from 2025 to 2035. The France intravenous infusion pumps market is driven by the high and growing prevalence of chronic diseases, such as cancer and diabetes, a strong emphasis on technological advancements and patient safety leading to the adoption of smart pumps, and increasing demand for home healthcare solutions. Other key drivers include favorable reimbursement policies, the need for precise and controlled drug delivery, and investments in modernizing healthcare facilities. 

Market Overview

The France intravenous infusion pumps market refers to the healthcare industry, which involves manufacturing, distributing, and supplying these specialized medical devices that automatically deliver medications, fluids, and nutrients to the bloodstream accurately, every time. The growth of the IV infusion pump industry can be attributed to the increasing prevalence of chronic diseases, aging populations, and the development of advanced drug delivery systems for both hospital and home use.

In France, the use of IV infusion pump technology is largely influenced by the national health statistics regarding chronic disease incidence, acute care, and age-related health issues. This correlates with the growth of outpatient services and hospitals that have seen a dramatic increase in patients who require continuous, precise dosing of medications, which has led to an influx of demand for more reliable, advanced infusion technology. The combination of these factors supports the increasing need for and the urgency of the IV infusion pumps market as a key contributor to the current and future framework of France’s health care system.

Under the France 2030 Plan and in particular concerning the special Health Sector Programme called Innovation Sante 2030, the government of France has committed considerable resources and infrastructure support to develop and enhance France’s medical device industry by supporting, encouraging, and accelerating the innovation process. For example, the France government has allocated €400 million specifically to assist companies that produce medical devices in an effort to re-industrialize the health tech sector in France and to facilitate access to the marketplace for these innovative devices. With this Financial Assistance Programme, hospitals and clinics will now be more willing to invest in state-of-the-art medical devices, such as infusion pumps, because of the support offered to these companies with respect to product development, industrialization, and compliance with regulatory standards. The support given to the manufacturers of medical devices by the Government of France will provide a more consistent, dependable, and high-quality product; stimulate Smart Connected Device development and, thus, fit into the overall goal of modernizing the healthcare system in France; and consequently, the long-term outlook for growth of the infusion pump market.

Report Coverage

This research report categorizes the market for the France intravenous infusion pumps market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France intravenous infusion pumps market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France intravenous infusion pumps market.

Driving Factors

The driving factors for the France intravenous infusion pumps market include the increasing prevalence of chronic diseases, a rapidly aging population, and a growing demand for home healthcare solutions. Additionally, the market is supported by favorable government reimbursement policies, like France has robust statutory health insurance (SHI) system, which provides universal coverage for residents, covering a wide range of medical services and products, including necessary medical equipment like infusion pumps, and a strong emphasis on patient safety and technological advancement in healthcare.

Restraining Factors

The main restraining factors for the France intravenous infusion pumps market include data protection regulations, which can hinder the integration of connected technologies like the Internet of Medical Things (IoMT). Other factors are the increasing number of products recalls due to safety issues or software errors, which erodes confidence and slows adoption, and stringent regulations that can slow the approval process for new products. 

Market Segmentation

The France intravenous infusion pumps market share is categorized by product type, application, and end user.

• The volumetric pumps segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The France intravenous infusion pumps market is segmented by product type into ambulatory infusion pumps, implantable infusion pumps, syringe pumps, volumetric pumps, infusion disposable sets, and others. Among these, the volumetric pumps accounted for the largest market share in 2024 and are expected to grow at a significant CAGR during the forecast period. The volumetric pump segmental growth is due to their high precision, versatility in handling large volumes, enhanced safety features, and reliability for administering critical and long-term infusions. Their ability to deliver a continuous, consistent flow rate is crucial for a wide range of medical treatments.

• The chemotherapy segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.  

The France intravenous infusion pumps market is segmented by application into diabetes, gastroenterology, chemotherapy, pediatrics, hematology, pain management, and others. Among these, the chemotherapy segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The chemotherapy segmental growth is primarily driven by the rise in cancer cases and the critical need for precise drug delivery. This segment's demand is further fueled by the increasing use of portable pumps for outpatient cancer treatments and the development of new oncological drugs. 

• The hospitals held the largest market share in 2024 and are anticipated to grow at a significant CAGR during the forecast period.

The France intravenous infusion pumps market is segmented by end user into hospitals, ambulatory care settings, home care settings, and others. Among these, the hospitals segment held the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. This segmental growth is due to the need for advanced treatments, emergency services, and a high number of patients requiring continuous and precise medication delivery in areas like critical care, surgical, and oncology units, as well as the presence of skilled healthcare professionals and advanced treatment facilities. 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France intravenous infusion pumps market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. 

List of Key Companies

• Glenmark Pharmaceuticals
• Eagle Pharmaceuticals Inc
• Astellas Pharma Inc
• Viatris Inc
• Cipla Ltd DR
• GSK PLC ADR
• Pfizer Inc
• Merck KGaA
• Baxter International Inc
• Johnson & Johnson
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In November 12, 2024, ICU Medical and Otsuka Pharmaceutical Factory announced a joint venture to enhance IV solutions manufacturing and innovation in North America, strengthening supply chain resilience and advancing medical device development.
• In January 2024, Lemer Pax, a global radiation protection leader, partnered with ICU Medical to distribute the Plum 360 infusion pump in France's nuclear medicine sector, aiming to expand sales across the European market.

Market Segment

This study forecasts revenue at the France, regional, and country levels from 2020 to 2035. Decision Advisors has segmented the France Intravenous Infusion Pumps Market based on the following segments:

France Intravenous Infusion Pumps Market, By Product Type 

• Ambulatory Infusion Pumps
• Implantable Infusion Pumps
• Syringe Pumps
• Volumetric Pumps
• Infusion Disposable Sets
• Others

France Intravenous Infusion Pumps Market, By Application

• Diabetes
• Gastroenterology
• Chemotherapy
• Pediatrics
• Hematology
• Pain Management
• Others

France Intravenous Infusion Pumps Market, By End User

• Hospitals
• Ambulatory Care Settings
• Home Care Settings
• Others

Frequently Asked Questions (FAQ)

1. What is the CAGR of the France intravenous infusion pumps market?

The France Intravenous Infusion Pumps market size is expected to grow at a CAGR of around 8.5% from 2024 to 2035

2. What is the France intravenous infusion pumps market size in 2024?

The France intravenous infusion pumps market size was estimated at USD 219.5 million in 2024.

3. What is the projected market size of the France intravenous infusion pumps market by 2035?

The France Intravenous Infusion Pumps market size is expected to reach USD 538.2 million by 2035

4. What are the main segments of the France intravenous infusion pumps market?

The France intravenous infusion pumps market share is segmented based on product type, application, and end user.

5. What are some drivers contributing to market growth?

France intravenous infusion pump market is driven by the increasing prevalence of chronic diseases, a rapidly aging population, and a growing demand for home healthcare solutions. Additionally, the market is supported by favorable government reimbursement policies and a strong emphasis on patient safety and technological advancement in healthcare.